Skip to content

Hexetidine and Chlorobutanol for Lesions Due to Prostheses

Evaluation of the Efficacy of a Hexetidine- and Chlorobutanol-based Mouthwash in the Symptomatic Treatment of Oral Lesions Due to Removable Prostheses: a Prospective, Randomized, Triple-blind Controlled Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01115049
Enrollment
44
Registered
2010-05-03
Start date
2010-02-28
Completion date
2010-03-31
Last updated
2010-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Mucositis

Brief summary

Objectives: The study aimed at assessing the efficacy of a new mouthwash in treating oral lesions due to removable prostheses. Methods: The present prospective randomized clinical trial was performed on 44 patients. The experimentation lasted for 4 weeks and 4 operators participated. The effects of the mouthwash were evaluated subjectively and objectively, with questionnaires, Visual Analogic Scales and clinical examinations. The results were statistically analyzed. The following variables were recorded: presence of mucosal lesions due to incongruous removable prostheses and lasting of pain after rinsing.

Detailed description

The aim of the present prospective, randomized, triple-blind controlled clinical trial was to evaluate the efficacy of an innovative mouthwash (emulsion) in the treatment of lesions of oral mucosae due to removable prostheses. The tested preparation contained two active molecules: a topical antiseptic (0.1% hexetidine) and a local anesthetic (0.5% chlorobutanol).

Interventions

DRUGchlorobutanol, hexetidine

3 times per day (after breakfast, lunch and dinner) for 1 minute with 15 ml of mouthwash

DRUGChlorhexidine

3 times per day (after breakfast, lunch and dinner) for 1 minute with 15 ml of mouthwash

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
37 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Use of removable partial or complete dentures; * Presence of lesions of oral mucosae due to dentures; * Absence of any concomitant local or systemic pathology; * Absence of pregnancy or breastfeeding; * Negative allergic anamnesis; * Negative anamnesis for recurrent aphthous stomatitis; * No taking medicines with potential pharmacologic interactions with molecules to be tested; * No taking antibiotics and/or painkillers for at least 6 months before entering the experimentation; * Good oral hygiene with a full-mouth plaque score ≤25%; * Non smoking or light smoking (≤10 cigarettes/day) status.

Exclusion criteria

Missing one or more of the above described conditions automatically excluded a subject from the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with adverse events as a measure of tolerabilityWeeklyPresence of mucosal lesions due to incongruous removable prostheses.

Secondary

MeasureTime frameDescription
Pain scores on the visual analogue scaleWeeklyLasting of painful symptomatology after rinsing.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026